Cancer Vaccine Industry, September 2014 Market Reports from Top Publishers

You might be interested in: cancer, vaccine, therapeutics, more »


 
1-10 of about 100 reports for Cancer Vaccine

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

... vaccines as anti-cancer therapiesfigure 5.5: T-cell based adoptive immunotherapyfigure 5.6: Availability of car-based adoptive immunotherapies ...

Bio-Bridge Science, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bio-Bridge Science, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Serum, which is a major production material in producing vaccines. The company owns the license of papillomavirus pseudovirus technology (original vaccine technology) for the hiv vaccine and colon cancer ...

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Asset transactions 32expres2ion biotech acquires ip rights related to recombinant protein production technology from affitech 32affitech completes sale of its remaining rights of cancer vaccine to gemvax 33 ...

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... And treatment of cancer and viral infections for the research and design of anti-viral and anti cancer vaccines. Altor is headquartered in miramar, florida, the us.Altor bioscience corporation ...

Serum Institute of India Limited - Product Pipeline Review - 2014

Serum Institute of India Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

... R&d progress 24bladder cancer vaccine 25product description 25mechanism of action 25r&d progress 25pneumococcal polysaccharide conjugate vaccine 26product description 26 ...

DNA Vaccines: Technologies and Global Markets

DNA Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

... Emerging competitive landscape for dna vaccines 31cancer dna vaccines 31table 15 cancer vaccine types 32dna vaccine technology value chain 33figure 5 dna vaccine technology value chain 33 ...

Immunovaccine, Inc. (IMV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immunovaccine, Inc. (IMV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... vaccine designed to train the immune system to recognize and attack cancer cells and dpx-survivac is a clinical-stage cancer vaccine. Imv's depovax platfrom is a patented vaccine delivery formulation ...

Immunicum AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immunicum AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Immunicum uses technologies such as combig and cd70 to develop therapeutic cancer vaccines. The company is formed as a spin- off from sahlgrenska university hospital. Immunicum is headquartered in gothenburg ...

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Neu breast cancer vaccine approach has the potential to treat 85% of her2/neu breast cancer patients. Its polystart vaccine is used to treat oncology and infectious diseases. The company's product ...

Adamis Pharmaceuticals Corporation (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Adamis Pharmaceuticals Corporation (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... To ytd 2014 10adamis pharma acquires cancer vaccine technology from the regents of the university of california 11adamis enters into co-development agreement with beximco 12adamis pharma ...

About 400 reports for Cancer Vaccine

Download Unlimited Documents from Trusted Public Sources

Drug Sales Demand in the US

  • Hbm New Drug Approval Report 2013
  • July 2013
    21 pages
  • Drug  

  • United States  

View report >

1 Companies for Cancer Vaccine

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.